Yas Holding completes acquisition of Gulf Inject LLC

GlobalOne Healthcare, Yas Holding's healthcare investment arm expands its value chain, further augmenting the UAE's manufacturing ambitions

Yas Holding completes acquisition of Gulf Inject LLC

Abu Dhabi, United Arab Emirates: UAE headquartered investment group Yas Holding LLC (YHL) has completed the acquisition of Gulf Inject LLC (GI) from Ras Al Khaimah-based Gulf Pharmaceutical Industries (Julphar), a listed UAE-based pharmaceutical company. The 100% acquisition, which includes Gulf Inject’s Jebel Ali Free Zone branch, was completed through Yas Holding’s dedicated healthcare investment vehicle, GlobalOne Healthcare Holding LLC (GHH).

GHH’s healthcare portfolio includes biopharma, manufacturing, medical supply chain, hospital and clinic management, healthcare technology, and occupational health and wellness.

The acquisition comes on the back of the UAE this week being announced as having the most competitive industrial sector in the Arab world, climbing five places to 30th in the world in the 2021 United Nations’ Industrial Organisation’s (UNIDO) Competitive Industrial Performance Index (CIP) report, which tracks 152 countries. The continuous improvement is in line with the UAE’s industrial strategy Operation 300bn, which aims to develop the country’s industrial sector and enhance its role in stimulating the national economy. 

Commenting on the latest acquisition, Mr. Murshed Al Redaini, Group Chief Executive Officer of Yas Holding, said “Yas Holding is pleased to announce our acquisition of Gulf Inject. The addition of their production facilities is of high strategic value to our growing healthcare manufacturing and distribution ecosystem. With this acquisition, Yas Holding continues to deliver on its commitment to improve health outcomes and enhance patient quality of life.”

Founded in 1994, Gulf Inject manufactures and distributes sterile parenteral solutions and is a leading player in fluid management therapy in the UAE. From its well-established production facility in JAFZA Dubai, GI manufactures 65 products including injectables, IV infusions, antibiotics, local anaesthetics and hypertonic solutions which are used for the treatment of critical and chronically ill patients.

Suresh Vaidhyanathan, Group CFO of Yas Holding, said: “The acquisition seeks to generate several synergies that collectively position GHH as a premier healthcare investment company in the region. The transaction further reinforces the aspirations of Yas Holding to be a leading investor in local manufacturing, and thereby aligning with UAE’s long-term strategic objectives.”

Ashraf Radwan CEO of GlobalOne Healthcare explained that “in combination with GHH’s Wellpharma Medical Solutions (WMS), this acquisition will see GHH assume a market leading position in the provision of domestic IV fluid, and among the top 3 regional players in the Middle East. Across Gulf Inject and WMS the combined production capacity will exceed 28 million units of general intravenous fluids, electrolytes and injectable antibiotics, 20 million units of small volume sterile product formulations and 1.2 million units of large volume formulations including dialysis solutions.”

He further added “Gulf Inject’s solutions will also be complemented by our existing range of therapeutic injectables and eye care products.” 


About GlobalOne Healthcare 

GlobalOne Healthcare Holding LLC (GHH) operates as the Healthcare Division of Yas Holding LLC. With investments in leading bio-pharmaceuticals and innovative manufacturing solutions, GHH is delivering on its commitment to improve healthcare outcomes and patient quality of life. GHH’s healthcare portfolio focuses on the provision of world-class healthcare services across a range of areas including customised clinical and non-clinical hospital management and healthcare consultancy services. Our companies specialise in biopharma, hospital management, medical supply chain, manufacturing, and occupational health. 

About Yas Holding LLC

Yas Holding is a UAE headquartered investment company with a multi-business portfolio spanning 9 sectors, 7,500 employees, and 60+ operating subsidiaries. The group is in an expansion phase, with increasing business interests in Agriculture, Food, Healthcare, Education, Aviation, Technology, Real Estate & Services. Yas Holding’s diverse companies operate across the Middle East, Africa, Europe, and Asia.

Yas Holding Contact:
Kerry Reid
Group Head of Marketing
Email: kerry.reid@yasholding.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases